Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

NCT: NCT05189314 · RECRUITING

NCT IDNCT05189314
StatusRECRUITING
Start Date2019-08-30
Completion2028-08

Brief Summary

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.

Frequently Asked Questions

What is RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study?

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study is a clinical trial registered under NCT05189314. Current status: RECRUITING.

What is the status of NCT05189314?

The current status of NCT05189314 (RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study) is: RECRUITING.

When did RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study start?

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study started on 2019-08-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑